Atlas Trials

Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease

Clinical trial NCT00056147 · COMPLETED

Trial details

NCT number
NCT00056147
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2003-04-01
Primary completion
2004-02-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.